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Abstract
Introduction: Inflammatory and protein mediators (cytokine, chemokine, acute phase proteins) play an important,
but still not completely understood, role in the morbidity and mortality of intra-abdominal sepsis/injury. We therefore
systematically reviewed preclinical and clinical studies of mediators in intra-abdominal sepsis/injury in order to evaluate
their ability to: (1) function as diagnostic/prognostic biomarkers; (2) serve as therapeutic targets; and (3) illuminate the
pathogenesis mechanisms of sepsis or injury-related organ dysfunction.
Methods: We searched MEDLINE, PubMed, EMBASE and the Cochrane Library. Two investigators independently reviewed
all identified abstracts and selected articles for full-text review. We included original studies assessing mediators
in intra-abdominal sepsis/injury.
Results: Among 2437 citations, we selected 182 studies in the scoping review, including 79 preclinical and 103
clinical studies. Serum procalcitonin and C-reactive protein appear to be useful to rule out infection or monitor
therapy; however, the diagnostic and prognostic value of mediators for complications/outcomes of sepsis or
injury remains to be established. Peritoneal mediator levels are substantially higher than systemic levels after
intra-abdominal infection/trauma. Common limitations of current studies included small sample sizes and lack
of uniformity in study design and outcome measures. To date, targeted therapies against mediators remain
experimental.
Conclusions: Whereas preclinical data suggests mediators play a critical role in intra-abdominal sepsis or injury,
there is no consensus on the clinical use of mediators in diagnosing or managing intra-abdominal sepsis or
injury. Measurement of peritoneal mediators should be further investigated as a more sensitive determinant of
intra-abdominal inflammatory response. High-quality clinical trials are needed to better understand the role of
inflammatory mediators.
Introduction
Sepsis is a syndrome that results from the interactions
between the host and insults (pathogen, injury) leading
to the production/release of biochemical mediators and
the triggering of inflammatory cascades [1]. Tissue dam-
age and shock lead to the extracellular release of damage-
associated molecular patterns (DAMPs), which evoke a
systemic inflammatory response syndrome (SIRS) and
hypoxia, reduce resistance to infection, and increase risk
of sepsis [2–4]. Moreover, microbial infection produces
pathogen-associated molecular patterns (PAMPs) that
drive septic inflammation. DAMPs and PAMPs share a
number of conserved families of pattern recognition re-
ceptors (PRRs) including the prototypical PRR family, the
Toll-like receptors (TLRs). Activation of TLRs on immune
cells and endothelial cells leads to the release of pro- and
anti-inflammatory mediators, which trigger excessive in-
flammation, sepsis and multiple organ failure (MOF) [5, 6].
Intra-abdominal infection and injury are common
causes of sepsis in surgical intensive care unit (ICU) pa-
tients, with high rates of mortality [7–9]. Early diagnosis
and treatment of infection in this group of patients is asso-
ciated with improved outcome and reduced mortality.
However, the clinical definitions of sepsis are nonspecific
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and often result in delay in diagnosis and therapy. One of
the most challenging obstacles to the treatment of intra-
abdominal infection and injury has been establishing the
diagnosis and differentiating sepsis with bacterial infection
from “sterile” SIRS [10].
Given that both intra-abdominal infection and injury
can incite hyperinflammatory status and sepsis, and the
inflammatory response to injury is often clinically indis-
tinguishable from sepsis, many studies have sought to
identify biomarkers or mediators to aid in the diagnosis
and management of sepsis [11, 12]. The purpose of this
scoping review was therefore to systematically review
preclinical and clinical studies of inflammatory media-
tors in abdominal sepsis and injury in order to evaluate
their ability to: (1) provide earlier diagnosis of SIRS,
sepsis or severe sepsis, or predict complications or out-
comes; (2) serve as therapeutic targets for randomized
controlled trials (RCTs); (3) illuminate the mechanisms
of pathogenesis of sepsis or injury-related organ
dysfunction.
Methods
We developed a protocol according to the Arksey and
O’Malley methodological framework for conducting scop-
ing reviews with modifications [13]. Scoping reviews entail
the systematic selection, collection and summarization of
existing knowledge in a broad thematic area for the pur-
pose of identifying if there is sufficient evidence to con-
duct a full synthesis or further research is needed.
Contrary to systematic reviews, in scoping reviews authors
do not typically assess the quality of included studies or
perform a meta-analysis [13].
Search strategy
Two investigators (ZX, AWK) created a preliminary
search strategy that was subsequently refined by a med-
ical librarian with extensive systematic review experience
(HLR). Relevant articles were identified by searching the
following databases from the first date available until
August 2014: Ovid MEDLINE; Ovid EMBASE; PubMed;
Cochrane Database of Systematic Reviews, and Cochrane
Central Register of Controlled Trials. Combinations of
the following search terms were used (see Table S1 in
Additional file 1 for detailed search strategies): abdominal
injuries, intraabdominal inflammation, intraabdominal
sepsis, intraabdominal infections, intraabdominal hyper-
tension, peritonitis, sepsis, septic shock, systemic inflam-
matory response syndrome, bacteremia, multiple organ
failure, inflammation mediator, cytokine, interleukin,
and biological markers. Appropriate wildcards were
used in all searches to account for plural words and
variations in spelling. Additional articles were identi-
fied by manually searching the bibliographies of those
articles identified in the searches until December
2014.
Article selection
Two investigators (ZX, CW) independently screened the
titles and abstracts of all identified citations. We in-
cluded all articles that were original studies (controlled
trials, cohort study, case series, case-control) assessing
inflammatory or protein mediators in intra-abdominal
sepsis or injury. Participants included patients (10 or
more) admitted for surgery with peritonitis or abdominal
injury, or animal models of abdominal sepsis/injury. Par-
ticipants required measurement of mediator(s) from
blood and/or peritoneal fluid for inclusion. Articles were
excluded if not reporting original data, such as reviews,
letters, and conference abstracts (no full text available).
Disagreements between the two assessors were resolved
by consensus.
Article review, data charting and reporting
The full texts of the remaining articles were independ-
ently reviewed by the same two authors. The two inves-
tigators extracted data independently using a
predesigned electronic data extraction form. Assessors
were not blinded to author or journal name [14]. We ex-
tracted the following data from included studies: (1)
study design and setting; (2) study participant character-
istics, including age, primary patient diagnosis (for
example, trauma, intra-abdominal sepsis, or source of
infection), and severity of illness (for example, acute
physiology and chronic health evaluation II (APACHE
II) [15], sequential organ failure assessment (SOFA) [16],
and injury severity score (ISS) [17]; (3) severity of sepsis
[10]; (4) the number of participants, and intervention
groups; (5) details of animal models; (6) details of
reported mediators; and (7) the outcomes.
Results were first mapped based on their characteris-
tics, such as study design, sample size, preclinical or
clinical studies. Owing to the significant variability in
study design, sample size, analytical technique and
outcome measures, it was impossible to perform a full
synthesis analysis of the findings. Therefore, studies were
presented in tables based on thematic characteristics of
the articles. In addition, the level of evidence for a
mediator as a biomarker was discussed based on the
“best-evidence synthesis” guideline used in review
studies (see Table S2 in Additional file 2) [18].
Risk of bias assessment
Risk of bias of clinical controlled studies was assessed
using the guidelines proposed by the Cochrane Collabor-
ation Back Review Group [19, 20]. These guidelines assist
in evaluating study patient participation and treatment al-
location, outcome, and confounding factor measurement.
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Results
The literature search identified 2412 studies (after dupli-
cates removed) and the search from reference lists identi-
fied an additional 25 articles. The review of abstracts led
to retrieval of 333 full-text articles for assessment. We
selected 182 articles for inclusion of this review (Fig. 1).
Characteristics of the articles
Table 1 summarizes the characteristics of the articles on
mediators in intra-abdominal sepsis or injury. Most articles
were published in the last two decades (92 %). There were
103 clinical studies (57 %) and 79 preclinical studies (43 %).
Among the clinical studies, 63 articles reported mediators
as biomarkers for diagnosis on or predicting outcomes of
intra-abdominal sepsis; 23 articles described the kinetic
change of mediators in intra-abdominal sepsis or injury;
and eight were mechanistic studies. Only nine intervention
studies with moderate methodological quality were identi-
fied concerning intra-abdominal sepsis management. Of
the 79 preclinical studies, rodent models and porcine
models were the most common animal models used.
Description of the studies and mediators
Table S3 in Additional file 3 summarizes the clinical
studies of mediators as biomarkers in diagnosing infection
or predicting outcomes of intra-abdominal sepsis and in-
juries. Studies of perioperative kinetic changes of mediators
are also included in this table. In general, before 1992, C-
reactive protein (CRP) was the most common mediator
studied [21–26]. Thereafter, interleukins (IL-6, -8, -10) and
tumor necrosis factor alpha (TNF-α) were on the top list
of the reported mediators [27–106]. Since 2000, procalci-
tonin (PCT) was often examined as a clinically prom-
ising biomarker [49, 57, 64, 66, 74, 77, 78, 88, 93, 95,
100, 101, 106]. Notably PCT was the only biomarker
being explored through randomized-type designs.
More recently, DAMPs and endothelial dysfunction
molecules had been added to the ever-growing list of
mediators [3, 63, 80, 82, 84, 85, 91, 99, 105].
C-reactive protein
There have been 33 studies exploring CRP as a marker
for abdominal infection or complications after surgery
Fig. 1 Flow chart of steps for study selection
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[21, 22, 24–27, 29, 32, 34, 39, 47, 49, 51–53, 57, 61, 64,
66, 68, 70, 79, 86–88, 90, 92, 95, 96, 98, 100, 103, 106].
Kinetics studies demonstrated that serum CRP levels
begun to elevate on postoperative day 1 (POD1), peaked
from POD2 to POD3 (approximately 12–24 hours after
peak levels of IL-6), and then declined to baseline levels
on POD5 providing there was no complication or infec-
tion after major abdominal surgery [29, 39, 52, 53, 57,
79, 90, 96]. Four reports suggested that persistent levels
of more than 100 mg/l after POD5 indicate abscess for-
mation or other septic complications (e.g., anastomotic
leakage) [21, 92, 98, 103]. Mustard et al. reported an
accuracy of 75 % for detecting infection when CRP was
greater than 15 mg/l after POD4 [24]. However, other
studies reported a limited role for CRP to diagnose
sepsis or predict outcomes in other clinical scenarios
[34, 49, 51, 64, 87, 88, 96].
Procalcitonin
Twelve trials (including two randomized controlled
studies) explored PCT as an indicator to diagnose infec-
tion, predict outcomes, or guide treatment of abdominal
Table 1 Characteristics of articles on inflammatory/protein mediators in intra-abdominal sepsis or injury
Characteristics Number (%) of 182 articles
Type of article
Clinical study 103 (57 %)
Biomarker or diagnosis study 63 (35 %)
Intervention study 9 (5 %)
Mechanistic or kinetic study 31 (17 %)
Study design
Randomized controlled trials 4





Abdominal injury or ischemia-reperfusion 27
Mixed sepsis and injury 12
Preclinical study 79 (43 %)
Intervention study 32 (17 %)







Injury or ischemia-reperfusion 26
Abdominal sepsis 44
Mixed injury and sepsis 9
Year of publication
1985–1994 14 (8 %)
1995–2004 65 (35 %)
2005–2014 103 (57 %)
Country of origin
European countries 80 (44 %)
United States of America 44 (24 %
Other countries 58 (32 %)
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sepsis or injury [49, 57, 64, 66, 74, 77, 78, 88, 93, 95,
100, 101]. Serum PCT increased immediately after surgi-
cal injury, peaked on POD1, and declined to half its peak
level from POD2 to POD3 after uncomplicated major
abdominal surgery [57, 66, 77, 100]. Reith et al. per-
formed a large case-control study of 246 patients with
abdominal sepsis [49]. The results from this study sug-
gested that serum PCT appeared to be a good predictor
of severity and mortality. A reduction of serum PCT on
POD1 to POD4 correlated with improvement in sepsis
[49]. Similar findings were reported by Mokart et al.
leading to the suggestion that a cutoff value of 1.1 ng/ml
serum PCT on POD1 was a good predictor of subse-
quent sepsis in patients undergoing major surgery [64].
Four studies suggested that PCT clearance kinetics ap-
pear to be a better indicator than a single cutoff value to
diagnose septic complications or predict outcomes. Per-
sistently high PCT in plasma was associated with infec-
tion or with a significant increase in mortality in
patients with sepsis in those studies [77, 88, 93, 95].
Therefore, PCT had been used as a guide for imaging or
interventions, or antibiotic therapy for patients with
abdominal sepsis [74, 78]. Importantly however, other
studies have not consistently confirmed PCT as an ac-
curate marker for sepsis or to predict patient’s response
to the initial treatment [100, 101].
Interleukin-6
Fifty-five of 86 studies examined IL-6, alone, or in con-
junction with other cytokines (TNF-α, IL-1, -2, -4, -8,
-10, -12, -18). IL-6 levels in plasma are rapidly dynamic
and peaking at maximum from wound closure to POD1.
IL-6 generally declined on POD1, and was back to base-
line on POD3 [29, 39, 40, 42, 43, 45, 49, 52–54, 61, 62,
75, 79, 90]. Patients with infection showed higher serum
IL-6 than those without complication after surgical in-
jury. However, the role of IL-6 as a marker to diagnose
sepsis or predict outcomes remains uncertain, and a
wide range of cutoff values had been used (from 12 to
2760 pg/ml). Fifteen studies reported that IL-6 appeared
to be an indicator for sepsis or for predicting outcome/
mortality [27, 36, 46–48, 50, 60, 62, 64, 70, 81, 82, 87,
89, 91]. Conversely however, nine studies suggested IL-6
was a poor marker of disease severity [28, 35, 55, 65, 66,
72, 80, 83, 96]. The role of other cytokines as markers,
such as IL-1β, -2, -4, -8, -10, -12, -18, and TNF-α also
remains elusive.
DAMPs
Recent studies have reported that DAMPs can act as
proinflammatory mediators. Cohen et al. demonstrated
high mobility group box protein 1 (HMGB1) was ele-
vated in plasma early after injury and shock. Levels of
HMGB1 correlated with injury severity and morbidity in
trauma patients [3]. Similar results had been reported by
Manganelli et al. in surgical patients [84]. HMGB1 level
of the patients with peritonitis was higher than healthy
controls [85, 99]. Mitochondrial DNA (mtDNA) has
been proposed to be an inflammatory mediator, which
was elevated early after trauma [105].
Intraperitoneal mediators
All studies that examined both systemic (blood) and
peritoneal levels of mediators demonstrated that peri-
toneal mediator levels were 10–1000 times higher than
systemic values in patients with peritonitis [33, 38, 51,
54, 61, 65, 67, 69, 71, 76, 89, 102]. This suggests that
measurement of peritoneal cytokines may be another
and potentially more important method to determine
and follow the patient’s inflammatory reaction.
Mechanistic studies
Table S4 in Additional file 4 summarizes the eight clinical
mechanistic studies that have been performed [107–114].
Moore et al. reported endotoxin could not be detected in
portal or systemic blood in the first 48 hours post injury,
and no differences were reported in terms of portal and
systemic blood levels of IL-6 and TNF-α between patients
who developed MOF or not [107]. However, Adembri et
al. carried out a small case-control study, and indicated a
significant increase in blood IL-6 after reperfusion in aor-
tic abdominal aneurysm surgery patients, which was
followed by a significant reduction of lung function [111].
Sperry et al. reported blood IL-6 levels were statistically
higher in males than females after injury [113]. In patients
with severe peritonitis, the percentage of peritoneal neu-
trophils that engulfed Escherichia coli bacteria was signifi-
cantly depressed when compared to patients without
septic shock [108]. Moreover, severe peritonitis provoked
an early pulmonary expression of chemoattractants, which
enhanced neutrophil sequestration and activation in the
lung [114].
Intervention studies
Table S5 in Additional file 5 lists the nine clinical inter-
vention studies [115–123]. Four of which were random-
ized controlled trials (RCT). Three of the RCTs were
from a single hospital comparing open surgery versus
laparoscopy for treating perforated appendicitis, perfo-
rated peptic ulcer, or cholecystitis with sepsis [120–122].
Bakker et al. compared surgical to endoscopic necrosect-
omy for the treatment of infected necrotizing pancreatitis
[119]. From these studies, the authors concluded that
open surgery after peritonitis increased the incidence of
bacteremia, endotoxemia, and systemic inflammation
compared with laparoscopy. However, despite the direct
linkage between endotoxin and inflammation, the use of
polymyxin B-immobilized fiber to remove endotoxin or
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inflammatory mediators by direct hemoperfusion has
proven to be of limited clinical value [116].
Kirkpatrick et al. performed a RCT looking at medi-
ator levels in 45 patients with intra-abdominal sepsis or
injury who needed open abdomen management, to de-
termine whether active negative pressure peritoneal
therapy with the ABThera device reduces systemic or
peritoneal inflammation [123]. In this study, a significant
90-day mortality difference (P = 0.04) was observed
among patients randomized to the ABThera (21.7 %)
versus Barker’s vacuum pack (50 %). Interestingly, there
was no significant difference in clearance of the periton-
eal or plasma IL-6 (or a number of other cytokines) be-
tween 24 and 48 hours among patients randomized to
the ABThera versus Barker’s vacuum pack.
Animal studies
Table S6 in Additional file 6 summarizes the mechanistic
studies of mediators in animal models [124–170].
Thirty-nine of the 47 studies used rodents to develop
abdominal sepsis models (i.e., cecum ligation and punc-
ture (CLP)) [124, 125, 127, 128, 131–133, 136–138, 143,
145, 151, 154, 156, 157, 159, 162, 164, 165, 167–170], or
shock-resuscitation, or abdominal compartment syn-
drome (ACS), or two-hit models [126, 130, 132, 135–
140, 142, 144, 146–150, 152, 160–162, 166]. The
remaining utilized swine [129, 134, 155, 158, 163], ba-
boons [141], or dogs [153]. These studies sought to ad-
dress a wide range of mechanisms using various study
designs. Four studies reported that balance of inflamma-
tory mediators was closely related to severity and out-
come of sepsis, and in these models IL-10 played a
critical role to attenuate local and systemic mediators in
animals with abdominal sepsis or injury [125–127, 140].
Ten reports used two-hit models, including shock (or is-
chemia) plus CLP or ACS [132, 134, 136, 137, 139, 155,
158, 163]. Overall these studies indicated that trauma or
shock (the first hit) initiated an early proinflammatory
response, resulting in priming and activation of neutro-
phils in peritoneum or other organs (lung, liver, kidney).
The second insult (infection or ACS) further exaggerated
this response, leading to MOF and mortality.
Studies also demonstrated that local (peritoneal) in-
flammatory mediator levels were not accurately reflected
by systemic (blood) mediator levels. Generally, periton-
eal mediator levels were much higher than the systemic
levels, and thus might be a truer or better indicator of
the local inflammatory response and outcomes [131,
154, 158, 163]. The release of local mediators into the
systemic circulation may help precipitate the deleterious
effects of SIRS and sepsis. The lymphatic pathway
appears to be a limiting step to systemic inflammatory
response and subsequent lung injury following visceral
ischemia and reperfusion [141, 153, 160].
Knockout animal studies demonstrated IL-10 was a
potent anti-inflammatory mediator, resulting in the
attenuation of lung neutrophil infiltration and injury
after visceral ischemia [140]. ICAM-1-deficient mice
undergoing CLP peritonitis showed better survival with
less tissue damage and lower levels of plasma cytokines
than their wild-type littermates [143]. Deficiency for the
chemoattractant MIP-1α attenuated Kupffer cell cytokine
production and systemic mediators following hemorrhage
shock and resuscitation [148].
Table S7 in Additional file 7 lists the preclinical inter-
vention studies performed on intra-abdominal sepsis
models [171–202]. Use of anti-TNF antibody in mice
subjected to CLP sepsis significantly reduced TNF-α
bioactivity but interestingly did not reduce mortality
[171, 172]. Administration of androgen receptor
blocker and estrogen receptor agonists (flutamide, de-
hydroepiandrosterone) ameliorated a male gender-
related immunity imbalance after hemorrhagic shock,
reduced cytokine production resulting in improved
animal survival during a subsequent septic challenge
[144, 147, 173, 174, 179, 185]. Treatment with anti-
HMGB1 antibody in mice after shock-resuscitation
improved survival and ameliorated gut barrier dysfunction
with lower blood cytokines [186]. Intravenous administra-
tion of a ω-3 fatty acid improved survival in mice CLP
sepsis, and reduced blood cytokine levels [196]. Kubiak et
al. reported that systemic and peritoneal inflammation
was reduced with less organ damage in pigs with periton-
itis treated by negative pressure therapy [190]. Although
animal studies appear promising, one should keep in mind
that many of these studies are small in nature. Further-
more, many limitations remain in translation of animal
data to clinical application. In animal models, the insults
are controlled; interventions can begin shortly after infec-
tion. In humans, the diagnosis is usually made much later.
Thus it is essential that more evidence for the use of these
interventions is gathered using clinical feasible models
and larger sample size studies.
Discussion
This scoping review focused on examining the reported
role of inflammatory and protein mediators in intra-
abdominal sepsis or injuries. In surgical ICU patients,
traumatic injuries and septic conditions can be simultan-
eously or subsequently present. Each can be associated
with profound and dynamic production of bioactive medi-
ators that are at the present poorly understood, particu-
larly in terms of their kinetics and overall interaction with
the host inflammatory response. This inflammatory re-
sponse is a complex and multifaceted process. Traumatic
injuries induce overwhelming reactions in the immuno-
logical and neurohormonal systems. Innate immunocytes
are activated by hypoxia stress and endogenous signals
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(DAMPs) released by damaged tissues [4, 6, 203]. These
reactions are thought to represent attempts to adjust
physiology for maintenance of homeostasis. These
responses however often result in positive feedback loops
leading to excessive cytokine production and uncontrolled
inflammation. In the early phase following injury, the
response is regulated by acute phase reactants, proin-
flammatory mediators (TNF-α, IL-1, -6, -8, -18), and
the activation of endothelial cells (expression of P-
and E-selectins, ICAM-1, VCAM-1), leading to a so-
called “sterile” systemic inflammatory response or
SIRS. At the same time, anti-inflammatory mediators
(IL-10) are released in an attempt to balance the
proinflammatory reaction. Polytrauma patients with
excessive SIRS can not only progress to multiple
organ damage and failure (MOF), but also develop
persistent inflammation, immunosuppression, and ca-
tabolism syndrome (PICS), which lead to infectious
sepsis resulting in release of additional DAMPs and
PAMPs, perpetuating a vicious cycle of inflammation
[4, 203]. Therefore, during this late phase post injury,
trauma patients are prone to develop infective com-
plications with high mortality rate. Injuries to the
abdomen and visceral organs are common clinical
scenarios, and are usually complicated with intra-
abdominal sepsis [123]. The objective of this scoping
review was to search for current evidence of media-
tors as biomarkers and their roles in intra-abdominal
sepsis or injury.
Although animal studies suggest that mediators play a
critical role in both the pathogenesis and potential man-
agement in intra-abdominal sepsis/injury, the clinical
evidence to support measuring mediators as biomarkers
to discriminate SIRS from sepsis is conflicting.
Due to the heterogeneity of included studies, we dis-
cussed the overall results based on the “best-evidence
synthesis” rating, which is widely used in narrative and
systematic reviews [18]. Moderate evidence supports
utilizing serum CRP as a biomarker for diagnosing acute
appendicitis with sepsis [25, 26, 32, 47, 70]; or as a
potential indicator for predicting complications (ab-
scess, anastomotic leaks) after major abdominal surgery
[21, 92, 98, 103]. A normal CRP response to therapy, or
absence of secondary rise after surgery, may help to
exclude infection [24]. It is important to note that no
standard cutoff value was available, and some studies
have reported negative results for using CRP as a
biomarker [64, 86, 96].
Furthermore, although the serum PCT value appears
to predict severity of septic complications [49, 64], it
does not appear to be an ideal biomarker to discriminate
SIRS from sepsis. Persistently high PCT levels appear to
be associated with a significant increase in mortality in
patients with sepsis [77, 88, 93, 95]. The role of using
serum PCT as a guide to monitor patients’ response to
therapy remains to be determined [74, 78].
Sepsis further increased IL-6 levels over the already el-
evated levels from the original injury. Although moder-
ate level of evidence supports IL-6 to be a useful
indicator for sepsis or severity [48, 64, 87, 91], it is im-
portant to note that almost half of the studies for this
cytokine do not support the use of IL-6 as a good sepsis
biomarker. Currently, no evidence is available to support
the use of TNF-α or other cytokines in diagnosing sepsis
or predicting outcomes. Recent studies have reported
endogenous DAMPs (mtDNA, HMGB1) released as a
consequence of tissue injury or infection appear to be
promising biomarkers [3, 84, 85, 99, 105]; however, the
evidence supporting their role is still limited.
It appeared to be futile to specifically target a single
inflammatory or protein mediator in an effort to miti-
gate disease and improve outcomes. It is more likely that
identifying promising biomarkers will only be possible
when a number of mediators are analyzed as a profile
[204, 205].
It is currently unknown if the peritoneal cavity func-
tions to restrain the inflammatory mediators or to act as
a reservoir of mediators. Evidence has shown that peri-
toneal fluid functions as a priming and activating stimu-
lus for neutrophils both in the peritoneum and in
remote organs (lung, liver, kidneys) after injury, enhan-
cing the incidence of MOF upon subsequent infection
[136, 163]. Moreover, early removal of peritoneal fluid
appeared to reduce systemic inflammation and organ
dysfunction [123, 141, 153, 160, 190]. This notion
supports the recent guidelines for management of
intra-abdominal infections proposed by the World Society
of Emergency Surgery [206].
Finally, based on the evidence from animal models
that injury followed by a second insult (infection, or
ACS) substantially enhanced the inflammatory response
and organ damage [134, 136, 158, 163, 190], it is essen-
tial to avoid or timely intervene upon secondary insults
for trauma patients to improve outcomes.
This review has limitations. First, despite the search of
multiple databases using comprehensive search strat-
egies with the assistance of a medical librarian, our
search has excluded studies assessing extra-abdominal
sepsis or injury. Moreover, limited abdominal trauma
studies were available; the majority of which focused on
surgical injuries. Importantly, the exclusion of studies
assessing other kinds of sepsis can present a selection
bias. Second, due to the inconsistencies in study design,
it proved difficult to extract accurate data from all stud-
ies, even with the assistance of predefined data abstrac-
tion tools. Furthermore, only a small number of the
included studies actually examined biomarkers for both
sensitivity and specificity.
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Conclusions
Systemic inflammatory response syndrome is the expected
immunologic response to both infection and traumatic in-
juries, which makes the distinction between infectious
sepsis and sterile SIRS exceedingly difficult. Although ani-
mal studies suggest that mediators play an important role,
the clinical use of mediators as biomarkers in discriminat-
ing SIRS from sepsis in intra-abdominal injury or sepsis is
conflicting. Persistent elevation of CRP or PCT levels in
blood appears to be correlated with septic complications.
The role of IL-6 as a biomarker in intra-abdominal sepsis
is controversial. Limited evidence suggests endogenous
molecules may be candidate biomarkers of sepsis or in-
jury. Importantly, peritoneal mediator levels cannot be
proportionately reflected by the systemic levels. Victims
subjected to trauma followed by infection show more ex-
cessive inflammatory response and organ damage than
those to trauma only. To date, therapies targeting a
specific inflammatory or protein mediator in abdom-
inal sepsis have shown poor results. Interventions
aiming to remove peritoneal fluid/mediators and improve
outcomes are still investigational. Large sample size ran-
domized controlled trails are desirable to identify the
“ideal” biomarker(s) and understand the roles of mediators
in intra-abdominal sepsis and injury.
Key messages
 Preclinical studies demonstrate that intra-abdominal
injury/ischemia, especially with subsequent infection,
induces an excessive inflammatory/protein mediator
production and uncontrolled inflammation in the
peritoneum and remote organs.
 Both preclinical and clinical studies have shown the
peritoneal mediator levels are much higher than the
blood levels, and the release of these mediators
(mostly via the lymphatic pathway) into the systemic
circulation may precipitate the deleterious effects of
sepsis and multiple organ dysfunction.
 Normal postoperative clearance kinetics of CRP,
PCT, or IL-6 may help rule out infection or
complications.
 The clinical role of measuring inflammatory/protein
mediators as biomarkers to diagnose abdominal
infection or predict outcomes of abdominal sepsis or
injury remains to be established. High-quality clin-
ical trials are warranted to determine the role of me-
diators in intra-abdominal sepsis and injury.
Additional files
Additional file 1: Table S1. Search strategies. (DOCX 17 kb)
Additional file 2: Table S2. Best-evidence synthesis. (DOCX 15 kb)
Additional file 3: Table S3. Clinical biomarkers. (DOCX 76 kb)
Additional file 4: Table S4. Clinical mechanism. (DOCX 19 kb)
Additional file 5: Table S5. Clinical intervention. (DOCX 22 kb)
Additional file 6: Table S6. Preclinical mechanism. (DOCX 46 kb)
Additional file 7: Table S7. Preclinical intervention. (DOCX 36 kb)
Abbreviations
ACS: abdominal compartment syndrome; CLP: cecum ligation and puncture;
CRP: C-reactive protein; DAMPs: damage-associated molecular patterns;
HMGB1: high mobility group box protein 1; ICU: intensive care unit;
IL: interleukin; mtDNA: mitochondrial DNA; MOF: multiple organ failure;
PAMPs: pathogen-associated molecular patterns; PCT: procalcitonin;
PICS: persistent inflammation, immunosuppression, and catabolism
syndrome; POD: postoperative day; PRRs: pattern recognition receptors;
RCT: randomized controlled trial; SIRS: systemic inflammatory response
syndrome; TLRs: Toll-like receptors; TNF: tumor necrosis factor.
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